“…In recent years, N-(arylsulfonyl)-arylamides have received much attention as they constitute an important class of drugs for Alzheimer's disease (Hasegawa & Yamamoto, 2000), anti-bacterial inhibitors of tRNA synthetases (Banwell et al, 2000), antagonists for angiotensin II (Chang et al, 1994) and as leukotriene D4-receptors (Musser et al, 1990). Further, N-(arylsulfonyl)-arylamides are known as potent antitumour agents against a broad spectrum of human tumour xenografts (colon, lung, breast, ovary and prostate) in nude mice (Mader et al, 2005).…”